TI - Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data
PT - Journal Article
DP - 2023
TA - EJMI
PG - 153-161
VI - 7
IP - 2
AID - 2023.22720 [doi]
4100 - https://dx.doi.org/10.14744/ejmi.2023.22720
SO - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION,2023 7(2): 153